Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis.

Autor: Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, University Hospital Zurich, 8091 Zurich, Switzerland.; Department of Urology, Luzerner Kantonsspital, 6004 Lucerne, Switzerland., Soria F; Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, 10124 Turin, Italy., Juvet T; Department of Urology, Lions Gate Hospital, North Vancouver, BC V7L 2L7, Canada., Potretzke AM; Department of Urology, Mayo Clinic, Rochester, MN 55902, USA., Djaladat H; Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA., Ghoreifi A; Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA., Kikuchi E; Department of Urology, St. Marianna University School of Medicine, Kawasaki 214-8525, Japan., Mari A; Department of Urology, University of Florence, Careggi Hospital, 50100 Florence, Italy., Khene ZE; Department of Urology, University of Rennes, 35000 Rennes, France., Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan., Raman JD; Department of Urology, Penn State Health, Hershey, PA 17033, USA., Breda A; Urology Department, Fundació Puigvert, Autonomous University of Barcelona, 08025 Barcelona, Spain., Fontana M; Urology Department, Fundació Puigvert, Autonomous University of Barcelona, 08025 Barcelona, Spain., Sfakianos JP; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Pfail JL; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, Medical University of Silesia, 40-752 Katowice, Poland., Pallauf M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, Paracelsus Medical University Salzburg, University Hospital Salzburg, 5020 Salzburg, Austria.; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA., Poyet C; Department of Urology, University Hospital Zurich, 8091 Zurich, Switzerland., Cacciamani GE; USC Institute of Urology, Keck Medicine of USC, University of Southern California, Los Angeles, CA 90007, USA., van Doeveren T; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Antonelli A; Department of Urology, Azienda Ospedaliera Universitaria Integrata of Verona, University of Verona, 37126 Verona, Italy., Jamil M; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI 48202, USA., Abdollah F; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI 48202, USA., Ploussard G; Department of Urology, UROSUD, La Croix Du Sud Hospital, 31130 Quint-Fonsegrives, France., Heidenreich A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, Uro-Oncology, Robot Assisted and Specialized Urologic Surgery, University Hospital Cologne, 50937 Cologne, Germany., Storz E; Department of Urology, Uro-Oncology, Robot Assisted and Specialized Urologic Surgery, University Hospital Cologne, 50937 Cologne, Germany., Daneshmand S; Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA., Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN 55902, USA., Rouprêt M; Urology Department, GRC n°5, Predictive Onco-Uro, AP-HP, Pitié-Salpêtrière Hospital, Sorbonne University, 75013 Paris, France., Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman 19328, Jordan.; Karl Landsteiner Institute of Urology and Andrology, 1090 Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA.; Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA.; Department of Urology, Second Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, UROSUD, La Croix Du Sud Hospital, 31130 Quint-Fonsegrives, France.
Jazyk: angličtina
Zdroj: Cancers [Cancers (Basel)] 2023 Feb 23; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 23.
DOI: 10.3390/cancers15051409
Abstrakt: Objectives: To identify correlates of survival and perioperative outcomes of upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), and robotic (RRNU) radical nephroureterectomy (RNU).
Methods: We conducted a retrospective, multicenter study that included non-metastatic UTUC patients who underwent RNU between 1990-2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment and were adjusted by 1:1:1 propensity score matching (PSM). Survival outcomes per group were estimated for recurrence-free survival (RFS), bladder recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS). Perioperative outcomes: Intraoperative blood loss, hospital length of stay (LOS), and overall (OPC) and major postoperative complications (MPCs; defined as Clavien-Dindo > 3) were assessed between groups.
Results: Of the 2434 patients included, 756 remained after PSM with 252 in each group. The three groups had similar baseline clinicopathological characteristics. The median follow-up was 32 months. Kaplan-Meier and log-rank tests demonstrated similar RFS, CSS, and OS between groups. BRFS was found to be superior with ORNU. Using multivariable regression analyses, LRNU and RRNU were independently associated with worse BRFS (HR 1.66, 95% CI 1.22-2.28, p = 0.001 and HR 1.73, 95%CI 1.22-2.47, p = 0.002, respectively). LRNU and RRNU were associated with a significantly shorter LOS (beta -1.1, 95% CI -2.2-0.02, p = 0.047 and beta -6.1, 95% CI -7.2-5.0, p < 0.001, respectively) and fewer MPCs (OR 0.5, 95% CI 0.31-0.79, p = 0.003 and OR 0.27, 95% CI 0.16-0.46, p < 0.001, respectively).
Conclusions: In this large international cohort, we demonstrated similar RFS, CSS, and OS among ORNU, LRNU, and RRNU. However, LRNU and RRNU were associated with significantly worse BRFS, but a shorter LOS and fewer MPCs.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje